Urinary Tract Infection Therapeutics Market with COVID-19 Impact Analysis, By Drug (Penicillin and Combinations, Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitrofurans, Others), By Indication (Complicated UTI, Uncomplicated UTI, Others), By Distribution Channel (Hospital, Pharmacies, Gynecology and Urology Clinics), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Urinary Tract Infection Therapeutics Market size was valued at USD 7,200 Million in 2022, expanding at a CAGR of 2.50 % from 2023 to 2030.
Urinary tract infection (UTI) therapies are a group of medical treatments and pharmacological interventions used to diagnose, prevent, and treat infections of the urinary system. UTIs are caused by bacterial infections in the bladder or urethra, which cause symptoms including pain, frequent urination, and discomfort. UTI treatments include antibiotics such as nitrofurantoin and ciprofloxacin, which target and kill the infection-causing bacteria. Additionally, supportive therapies may include analgesics for discomfort alleviation and infection prevention techniques. UTI treatments are critical in giving comfort, avoiding complications such as kidney infections, and increasing the quality of life for those suffering from these prevalent and sometimes severe diseases.
Urinary Tract Infection Therapeutics Market- Market Dynamics
- Growing concern over antibiotic resistance propel market demand
As the bacteria that cause UTIs gain resistance to frequently used antibiotics, there is an urgent need for the development of new and more effective therapies. This has fueled research and development efforts to identify new antimicrobial drugs, investigate alternative treatment modalities such as vaccinations, and encourage responsible antibiotic usage in order to reduce resistance. The growing issue of antibiotic-resistant UTIs encourages pharmaceutical firms, researchers, and healthcare professionals to explore creative ways to keep UTIs manageable and patients receiving effective therapy even as bacterial resistance evolves.
Urinary Tract Infection Therapeutics Market- Key Insights
- As per the analysis shared by our research analyst, the global Urinary Tract Infection Therapeutics market is estimated to grow annually at a CAGR of around 2.50% over the forecast period (2023-2030)
- The Urinary Tract Infection Therapeutics industry is projected to grow at a significant rate due to growing concern over antibiotic resistance.
- Based on Drug segmentation, Penicillin and Combinations was predicted to show maximum market share in the year 2022
- Based on Indication segmentation, Complicated UTI was the leading Drug in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Urinary Tract Infection Therapeutics Market- Segmentation Analysis:
The Global Urinary Tract Infection Therapeutics Market is segmented on the basis of Drug, Indication, Distribution Channel, and Region.
The market is divided into five categories based on Drug: Penicillin and Combinations, Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitrofurans, Others. The Penicillin and Combinations dominates the market. Because of their efficiency in treating some UTI-causing bacteria, penicillin and combination medicines are in high demand as urinary tract infection (UTI) therapies. These antibiotics are part of the treatment arsenal for uncomplicated UTIs, providing patients and healthcare professionals with dependable alternatives for treating these prevalent illnesses.
The market is divided into three categories based on Indication: Complicated UTI, Uncomplicated UTI, Others. The Complicated UTI sector dominates the market and is likely to maintain its dominance during the forecast period. Because of their efficiency in treating some UTI-causing bacteria, penicillin and combination medicines are in high demand as urinary tract infection (UTI) therapies. These antibiotics are part of the treatment arsenal for uncomplicated UTIs, providing patients and healthcare professionals with dependable alternatives for treating these prevalent illnesses.
Urinary Tract Infection Therapeutics Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several variables impact the need for urinary tract infection (UTI) medicines in the Asia-Pacific area. The region\'s high population density and urbanization lead to a rise in UTIs owing to greater exposure to possible risk factors. Additionally, improved healthcare facilities and accessibility to medical services have resulted in improved diagnosis and treatment, as well as increased awareness of UTIs. Furthermore, lifestyle and nutritional changes may lead to UTIs. Finally, the growing older population makes UTIs more likely. Pharmaceutical firms and healthcare professionals are treating UTIs as a key public health problem in the Asia-Pacific region as healthcare awareness grows and demand for effective medicines increases.
Urinary Tract Infection Therapeutics Market- Competitive Landscape:
The competitive environment in urinary tract infection (UTI) medicines is crowded with pharmaceutical firms fighting for a piece of the pie. Furthermore, generic versions of commonly used antibiotics are generally accessible. Startups and smaller businesses also contribute to the industry by developing new treatment and preventative approaches. Companies are focused on research to produce new, more effective UTI medicines as worries about antibiotic resistance rise. The competition in the market pushes the development of alternative medicines, vaccinations, and non-antibiotic techniques, providing patients with a larger choice of UTI management alternatives.
Recent Developments:
- In April 2023, GSK (GSK.L), a British pharmaceutical company, revealed that its oral antibiotic medication for treating uncomplicated urinary tract infections (uUTI) in female adults and adolescents fulfilled the primary objectives in late-stage studies. The medicine, gepotidacin, accomplished its key aims of being on par with or better than nitrofurantoin, the current course of care for the therapy of uUTIs, according to the manufacturer.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET KEY PLAYERS
- AstraZeneca
- GlaxoSmithKline
- Merck & Co., Inc.
- Pfizer Inc.
- Allergan
- Novartis
- Bayer AG
- Johnson & Johnson
- Ferring Pharmaceuticals
- Cipla
- Sun Pharmaceutical Industries
- Lupin Limited
- Teva Pharmaceuticals
- Reddy\'s Laboratories
- Zydus Cadila
GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET, BY DRUG
- Penicillin and Combinations
- Quinolones
- Cephalosporin
- Azoles and Amphotericin B
- Nitrofurans
- Others
GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET, BY INDICATION
- Complicated UTI
- Uncomplicated UTI
- Others
GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL
- Hospital
- Pharmacies
- Gynecology and Urology Clinics
GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
Rest of MEA
TABLE OF CONTENT
1. Urinary Tract Infection Therapeutics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Urinary Tract Infection Therapeutics Market Snippet by Drug
2.1.2. Urinary Tract Infection Therapeutics Market Snippet by Indication
2.1.3. Urinary Tract Infection Therapeutics Market Snippet by Distribution Channel
2.1.4. Urinary Tract Infection Therapeutics Market Snippet by Country
2.1.5. Urinary Tract Infection Therapeutics Market Snippet by Region
2.2. Competitive Insights
3. Urinary Tract Infection Therapeutics Key Market Trends
3.1. Urinary Tract Infection Therapeutics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Urinary Tract Infection Therapeutics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Urinary Tract Infection Therapeutics Market Opportunities
3.4. Urinary Tract Infection Therapeutics Market Future Trends
4. Urinary Tract Infection Therapeutics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Urinary Tract Infection Therapeutics Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Urinary Tract Infection Therapeutics Market Landscape
6.1. Urinary Tract Infection Therapeutics Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Urinary Tract Infection Therapeutics Market – By Drug
7.1. Overview
7.1.1. Segment Share Analysis, By Drug, 2022 & 2030 (%)
7.1.2. Penicillin and Combinations
7.1.3. Quinolones
7.1.4. Cephalosporin
7.1.5. Azoles and Amphotericin B
7.1.6. Nitrofurans
7.1.7. Others
8. Urinary Tract Infection Therapeutics Market – By Indication
8.1. Overview
8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
8.1.2. Complicated UTI
8.1.3. Uncomplicated UTI
8.1.4. Others
9. Urinary Tract Infection Therapeutics Market – By Distribution Channel
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
9.1.2. Hospital
9.1.3. Pharmacies
9.1.4. Gynecology and Urology Clinics
10. Urinary Tract Infection Therapeutics Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Urinary Tract Infection Therapeutics Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Urinary Tract Infection Therapeutics Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Urinary Tract Infection Therapeutics Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Urinary Tract Infection Therapeutics Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Urinary Tract Infection Therapeutics Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Urinary Tract Infection Therapeutics Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. AstraZeneca
11.2.2. GlaxoSmithKline
11.2.3. Merck & Co., Inc.
11.2.4. Pfizer Inc.
11.2.5. Allergan
11.2.6. Novartis
11.2.7. Bayer AG
11.2.8. Johnson & Johnson
11.2.9. Ferring Pharmaceuticals
11.2.10. Cipla
11.2.11. Sun Pharmaceutical Industries
11.2.12. Lupin Limited
11.2.13. Teva Pharmaceuticals
11.2.14. Dr. Reddy\'s Laboratories
11.2.15. Zydus Cadila
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
